The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux

[1]  G. Suaifan,et al.  Erratum to "Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?" [Bioorg. Med. Chem. 27 (2019) 3005-3060]. , 2019, Bioorganic & medicinal chemistry.

[2]  G. Suaifan,et al.  Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now? , 2019, Bioorganic & medicinal chemistry.

[3]  P. Ruggerone,et al.  Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB. , 2019, The journal of physical chemistry. B.

[4]  P. Ruggerone,et al.  Computer simulations of the activity of RND efflux pumps. , 2018, Research in microbiology.

[5]  Heba A. Hassan,et al.  Recent updates of fluoroquinolones as antibacterial agents , 2018, Archiv der Pharmazie.

[6]  T. Khan,et al.  DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  J. Sączewski,et al.  Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules , 2018, Monatshefte für Chemie - Chemical Monthly.

[8]  B. Cinquin,et al.  Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes , 2018, Nature Protocols.

[9]  P. Ruggerone,et al.  Water-mediated interactions enable smooth substrate transport in a bacterial efflux pump. , 2018, Biochimica et biophysica acta. General subjects.

[10]  Lian-Shun Feng,et al.  4-Quinolone derivatives and their activities against Gram positive pathogens. , 2018, European journal of medicinal chemistry.

[11]  Zhi Xu,et al.  4-Quinolone hybrids and their antibacterial activities. , 2017, European journal of medicinal chemistry.

[12]  B. Cinquin,et al.  Fluoroquinolone structure and translocation flux across bacterial membrane , 2017, Scientific Reports.

[13]  Michelle F. Richter,et al.  Predictive compound accumulation rules yield a broad-spectrum antibiotic , 2017, Nature.

[14]  W. Chiu,et al.  An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump , 2017, eLife.

[15]  J. Pagés,et al.  Erratum: Unusual marine unicellular symbiosis with the nitrogen-fixing cyanobacterium UCYN-A , 2017, Nature Microbiology.

[16]  G. Jacoby,et al.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance. , 2016, Cold Spring Harbor perspectives in medicine.

[17]  R. Bonomo,et al.  Overview: Global and Local Impact of Antibiotic Resistance. , 2016, Infectious disease clinics of North America.

[18]  P. Ruggerone,et al.  Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives , 2016, Proceedings of the National Academy of Sciences.

[19]  R. Laxminarayan,et al.  Access to effective antimicrobials: a worldwide challenge , 2016, The Lancet.

[20]  B. Cinquin,et al.  Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level , 2015, Scientific Reports.

[21]  Russell Lewis,et al.  Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. , 2015, Current opinion in pharmacology.

[22]  S Gnanakaran,et al.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. , 2015, ACS infectious diseases.

[23]  C. Nakajima,et al.  Characterization of Salmonella Typhimurium DNA gyrase as a target of quinolones. , 2015, Drug testing and analysis.

[24]  P. Ruggerone,et al.  A Database of Force-Field Parameters, Dynamics, and Properties of Antimicrobial Compounds , 2015, Molecules.

[25]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[26]  G. Bisacchi.  Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story". , 2015, Journal of medicinal chemistry.

[27]  M. Webber,et al.  Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.

[28]  M. Winterhalter,et al.  TRANSLOCATION Project: How to Get Good Drugs into Bad Bugs , 2014, Science Translational Medicine.

[29]  N. Osheroff,et al.  Mechanism of Quinolone Action and Resistance , 2014, Biochemistry.

[30]  A. Yamaguchi,et al.  Structural basis for the inhibition of bacterial multidrug exporters , 2013, Nature.

[31]  Ronald N. Jones,et al.  10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  H. Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2009, Drugs.

[33]  Attilio V Vargiu,et al.  Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations , 2012, Proceedings of the National Academy of Sciences.

[34]  K. Diederichs,et al.  Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop , 2012, Proceedings of the National Academy of Sciences.

[35]  H. Nikaido,et al.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. , 2012, FEMS microbiology reviews.

[36]  Keisuke Sakurai,et al.  Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket , 2011, Nature.

[37]  Darren V S Green,et al.  Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity. , 2011, Drug discovery today.

[38]  Daniel Jones.  The antibacterial lead discovery challenge: a recent report provides a rare example of a potential new class of antibiotics. Dan Jones investigates the difficulties of finding such drugs , 2010 .

[39]  Jason A. Wiles,et al.  New quinolone antibiotics: a survey of the literature from 2005 to 2010 , 2010, Expert opinion on therapeutic patents.

[40]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[41]  B. Eisenstein.  The antibacterial lead discovery challenge , 2010, Nature Reviews Drug Discovery.

[42]  V. Belakhov,et al.  Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics. , 2009, Journal of medicinal chemistry.

[43]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  M. Winterhalter,et al.  The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria , 2008, Nature Reviews Microbiology.

[45]  Yuan Zhao,et al.  Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge , 2007, J. Chem. Inf. Model..

[46]  P. Tulkens,et al.  Quinolones in 2005: an update. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[47]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[48]  S. Hagen,et al.  Structure-Activity Relationships of the Quinolone Antibacterials in the New Millennium: Some Things Change and Some Do Not , 2003 .

[49]  Hisashi Takahashi,et al.  [The history of the development and changes of quinolone antibacterial agents]. , 2003, Yakushigaku zasshi.

[50]  Peter A. Kollman,et al.  Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models , 2001 .

[51]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[52]  D. King,et al.  New classification and update on the quinolone antibiotics. , 2000, American family physician.

[53]  V. Jarlier,et al.  Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. , 1999, Microbiology.

[54]  Berk Hess,et al.  Improving efficiency of large time‐scale molecular dynamics simulations of hydrogen‐rich systems , 1999, Journal of computational chemistry.

[55]  H. Simmen,et al.  Bacterial concentrations in pus and infected peritoneal fluid--implications for bactericidal activity of antibiotics. , 1998, The Journal of antimicrobial chemotherapy.

[56]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[57]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[58]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[59]  K. Johnson.  An Update. , 1984, Journal of food protection.

[60]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .